Presidio Pharmaceuticals, Inc.

The golden days for some drugs in China seem to be passing, and manufacturers are preparing to battle sizzling competition by raising cash and focusing more on profitable innovative therapies as deman

Chinese antiviral-focused venture Ascletis Pharma Inc. became the first biotech company to take advantage of revised and eased rules for the listing of pre-revenue/pre-profit ventures on the Hong Ko

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal i